On November 8, 2022, the Company received the resignation of Maxine Gowen from her role as Interim Executive Chairwoman of the Board of Directors of the Company (the Board), effective as of November 10, 2022 (the Effective Date). On the Effective Date, Dr. Gowen will resume her status as an independent director and will remain Chairwoman of the Board. Dr. Gowen will also resume her role as a member of the Board's Compensation Committee and as a member and the Chairwoman of the Nominating and Corporate Governance Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.48 USD | +0.68% | +4.96% | +46.53% |
04/03 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04/03 | Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.53% | 91.19M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.56% | 21.93B | |
-12.15% | 22.34B | |
-5.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Passage Bio, Inc. Announces Resignation of Maxine Gowen as Interim Executive Chairwoman